The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its own. It was approved in 2019 to treat severe depression.
#
news #
npr #
publicradio #
usaposted by
pod_feeder_v2Publishes RSS/Atom feeds to Diaspora*
GitLab